PPARγ-Axl axis ameliorates intervertebral disc degeneration by activating PI3K/AKT-mediated autophagy to suppress ferroptosis

Guantong Sun, Derong Xu, Yufeng Jiang, Kang‐Yi Su, Jun Lü, Chuanli ZhouCellular 2025 · DOI

Abstract

Intervertebral disc degeneration (IVDD) is a primary cause of chronic low back pain, characterized by the death of nucleus pulposus cells (NPCs) and degradation of the extracellular matrix (ECM). Recent evidence highlights ferroptosis—an iron-dependent form of regulated cell death—as a significant contributor to IVDD. This study investigates the protective role of Peroxisome proliferator-activated receptor gamma (PPARγ) against ferroptosis. Using rat models and in vitro NPC cultures, researchers identified that PPARγ activates a novel PPARγ-Axl signaling axis. This axis promotes PI3K/AKT-mediated autophagy, which in turn suppresses oxidative stress-induced ferroptosis and maintains ECM homeostasis. These findings suggest that targeting the PPARγ-Axl axis could offer a new therapeutic strategy for treating IVDD.

Introduction

Low back pain (LBP) represents a massive global health and economic burden. Its primary underlying cause is Intervertebral Disc Degeneration (IVDD), a condition marked by the dysfunction and depletion of nucleus pulposus cells (NPCs). These cells are responsible for maintaining the gel-like, shock-absorbing core of the spinal disc. When NPCs die, the extracellular matrix (ECM) breaks down, leading to structural failure of the disc.

Recent research has identified ferroptosis—triggered by iron overload and toxic lipid peroxidation—as a major driver of NPC death in the oxidative microenvironment of a degenerating disc. This study explores whether PPARγ, a nuclear receptor known for regulating lipid metabolism, can serve as a master regulator to halt ferroptosis and preserve disc integrity.

Methodology

The study utilized a combination of in vivo animal models and in vitro cellular assays:

  • Animal Models: IVDD was induced in rat tails via needle puncture. Treatments included localized injections of pioglitazone (a PPARγ agonist), Fer-1 (a ferroptosis inhibitor), or viral vectors (AAVs and lentiviruses) for gene overexpression or knockdown.
  • Cell Culture: Rat primary NPCs were subjected to oxidative stress using tert-butyl hydroperoxide (TBHP) or interleukin (IL)-1β to simulate the degenerative environment.
  • Molecular Analysis: Techniques included Western blotting, RT-qPCR, immunofluorescence, and Transmission Electron Microscopy (TEM) to observe mitochondrial changes. Lipid reactive oxygen species (ROS) were measured using BODIPY staining.
  • Mechanistic Discovery: RNA-sequencing (RNA-seq) identified differentially expressed genes. ChIP-qPCR and Co-Immunoprecipitation (Co-IP) confirmed direct DNA-binding and protein-protein interactions between PPARγ and its targets.

Key Insights: The PPARγ-Axl Signaling Axis

The researchers demonstrated that PPARγ levels significantly decrease during IVDD. Artificially restoring PPARγ levels does not just improve general cell health; it specifically inhibits ferroptosis and prevents the breakdown of essential ECM components like collagen and aggrecan.

Graphical abstract illustrating the PPARγ-Axl signaling axis in mitigating ferroptosis and preserving ECM homeostasis in nucleus pulposus cells.

A critical discovery was the "Autophagy Bridge." PPARγ does not inhibit ferroptosis directly. Instead, it upregulates autophagy—the cell's internal recycling mechanism. Through RNA-seq and binding assays, the team identified a novel interaction: PPARγ binds directly to the promoter of the Axl gene (a receptor tyrosine kinase). Axl then activates the PI3K/AKT pathway, triggering the protective autophagy that neutralizes ferroptotic triggers.

Key Results

  • In Vitro Rescue: Treatment with pioglitazone or Fer-1 reduced intracellular iron and malondialdehyde (MDA) levels, restored antioxidant activity (GSH), and suppressed matrix-degrading enzymes (e.g., MMP13).
  • Loss of Function: Knocking down PPARγ or Axl exacerbated cell death, increased ROS levels, and accelerated ECM degradation.
  • In Vivo Preservation: Injections of AAV-PPARγ in rat models successfully preserved the Disc Height Index (DHI) and maintained healthy tissue hydration signals on MRI, effectively halting physical degeneration.
  • Pathway Confirmation: Using a dual-inducible viral system, the researchers showed that Axl overexpression could reverse the damage caused by PPARγ knockdown, confirming Axl as the essential downstream effector.

Conclusion and Future Directions

This study establishes the PPARγ-Axl axis as a pivotal regulator of NPC survival in the face of oxidative stress. By promoting autophagy, this pathway effectively suppresses ferroptosis and maintains the structural integrity of the intervertebral disc.

While promising, the study has limitations. The findings rely on rat models and require validation in human NPCs to ensure clinical relevance. Additionally, while the PPARγ-Axl axis is a primary focus, PPARγ likely interacts with other pathways (such as Nrf2) that may also contribute to its protective effects. Future research should explore these broader interactions and the potential for PPARγ agonists or gene therapies in human clinical trials for IVDD.

Summary updated

Abstract

Peroxisome proliferator-activated receptors (PPARs) play a critical role in the development of intervertebral disc degeneration (IVDD), a major contributor to chronic low back pain (LBP). This condition is characterized by excessive nucleus pulposus cell (NPC) death, which contributes to degradation of the extracellular matrix (ECM). Ferroptosis, an iron-dependent cell death mechanism, has emerged as a key player in IVDD. However, the underlying mechanism and pathogenesis remain incompletely understood. In this study, we aimed to assess the function of PPARγ in IVDD and its modulation of ferroptosis in vivo using rat models of IVDD and in vitro using NPC cultures treated with oxidative stress-inducing agents, such as tert-butyl hydroperoxide (TBHP) and interleukin (IL)-1β. NPC treatment with PPARγ agonist (pioglitazone) and inhibitor of ferroptosis (ferrostatin-1; Fer-1) maintained ECM homeostasis by downregulating matrix metalloproteinases and ferroptosis indicators and upregulating anabolic factors. Conversely, PPARγ knockdown exacerbated ferroptosis and ECM degradation, underscoring its protective effects against oxidative stress-induced ferroptosis in NPCs. PPARγ regulates ferroptosis and ECM homeostasis through autophagy. RNA-sequencing, chromatin immunoprecipitation followed by quantitative polymerase chain reaction (ChIP-qPCR) and co-immunoprecipitation (Co-IP) assays confirmed Axl as a novel binding partner of PPARγ. Furthermore, using a Tet-on dual-inducible system, we demonstrated the involvement of the PPARγ-Axl axis in the alleviation of oxidative stress-induced ferroptosis by autophagy. In vivo, PPARγ overexpression in intervertebral disc (IVD) alleviated IVDD in rat models. In summary, these findings reveal a pivotal role for the PPARγ-Axl axis in mitigating ferroptosis and preserving ECM homeostasis in NPC via autophagy, providing a new therapeutic strategy for IVDD.
BibTeX
@inproceedings{sun2025ppar,
  author = {Guantong Sun and Derong Xu and Yufeng Jiang and Kang‐Yi Su and Jun Lü and Chuanli Zhou},
  title = {{PPARγ-Axl axis ameliorates intervertebral disc degeneration by activating PI3K/AKT-mediated autophagy to suppress ferroptosis}},
  booktitle = {Cellular},
  year = {2025},
  doi = {10.1186/s11658-025-00802-x},
}
Figure